Document ID: chunk:federal_register_of_legislation:F2025L00212:clause:1_1699
Version: federal_register_of_legislation:F2025L00212
Segment Type: clause
Provision Reference: sch 1 cl 1699
Character Range: 820277–821432

1699                                      D-GLUCOSE, POLYMER WITH XYLITOL                                                                  E         The route of administration for medicines that contain D-glucose, polymer with xylitol must be limited to topical for dermal use.
                                                                                                                                                     The total concentration of D-glucose, polymer with xylitol in the medicine must not be more than 5%.
                                                                                                                                                     The following warning statements (or words to the same effect) are required on the medicine label:
                                                                                                                                                     - (EYE) 'Avoid contact with eyes'; and
                                                                                                                                                     - (BROKEN) 'Use on unbroken skin only'.